FSD Pharma Operating Income

FSD Pharma (HUGE) currently reports a operating income of $-11M as of June 2024. That compares with $-33M in the prior-year period — up 66.0% year over year. Use the charts on this page to explore FSD Pharma's operating income history and peer comparisons.

FSD Pharma's operating income increased from $-33M to $-11M — a 66.0% year-over-year increase (period ending June 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

FSD Pharma reported $-11M in operating income as of June 2024. That compares with $-33M in the prior-year period — up 66.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-11M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for FSD Pharma, and consider following HUGE for alerts when major investors trade the stock.

FSD Pharma is classified in the Healthcare sector. On operating income, it currently shows $-11M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing HUGE with unrelated industries.